Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study

• Published in: Alimentary pharmacology & therapeutics Vol. 44; no. 6; pp. 592 - 600
• Main Authors: Koloski, N. A., Jones, M., Talley, N. J.
• Format: Journal Article
• Language: English
• Published: England 01.09.2016
• Subjects: Adult; Aged; Aged, 80 and over; Anxiety - complications; Anxiety - epidemiology; Anxiety - physiopathology; Anxiety Disorders - complications; Anxiety Disorders - epidemiology; Anxiety Disorders - physiopathology; Australia - epidemiology; Brain - physiology; Depression - complications; Depression - epidemiology; Depression - physiopathology; Depressive Disorder - complications; Depressive Disorder - epidemiology; Depressive Disorder - physiopathology; Dyspepsia - epidemiology; Dyspepsia - etiology; Dyspepsia - physiopathology; Dyspepsia - psychology; Female; Gastrointestinal Diseases - epidemiology; Gastrointestinal Diseases - etiology; Gastrointestinal Diseases - physiopathology; Gastrointestinal Diseases - psychology; Humans; Intestines - physiology; Irritable Bowel Syndrome - epidemiology; Irritable Bowel Syndrome - etiology; Irritable Bowel Syndrome - physiopathology; Irritable Bowel Syndrome - psychology; Male; Middle Aged; Prevalence; Psychophysiologic Disorders - epidemiology; Surveys and Questionnaires
• DOI: 10.1111/apt.13738
• ISSN: 0269-2813

Summary Background Traditionally, functional gastrointestinal disorders (FGIDs) are conceptualised as originating in the brain via stress pathways (brain‐to‐gut). It is uncertain how many with irritable bowel syndrome (IBS) and functional dyspepsia (FD) have a gut origin of symptoms (gut‐to‐brain pathway). Aims To determine if there is a distinct brain‐to‐gut FGID (where psychological symptoms begin first) and separately a distinct gut‐to‐brain FGID (where gut symptoms start first). Methods A prospective random population sample from Newcastle, Australia who responded to a validated survey in 2012 and completed a 1‐year follow‐up survey (n = 1900). The surveys contained questions on Rome III IBS and FD and the Hospital Anxiety and Depression Scale. Results We found that higher levels of anxiety and depression at baseline were significant predictors of developing IBS (OR = 1.31; 95% CI 1.06–1.61, P = 0.01; OR = 1.54; 95% CI 1.29–1.83, P < 0.001) and FD (OR = 1.28; 95% CI 1.05–1.55, P = 0.01; OR = 1.55, 95% CI 1.32–1.83, P < 0.001), respectively, at the 1‐year follow‐up. Among those people who did not have elevated levels of anxiety and depression at baseline, subjects at baseline with documented IBS (mean difference 0.34; 95% CI 0.13–0.55, P = 0.002; 0.81; 95% CI 0.47–1.15, P < 0.001) and FD (0.38; 95% CI 0.14–0.63, P = 0.002; 0.92; 95% CI 0.57–1.27, P < 0.001), reported significantly higher levels of anxiety and depression at the 1‐year follow‐up. We calculated in one‐third of individuals a mood disorder precedes FGID but in two‐thirds an FGID precedes the mood disorder. Conclusion While brain–gut pathways are bidirectional, a major subset begin with gut symptoms first and only then psychological distress develops, implicating primary gut mechanisms as drivers of the gut and extra‐intestinal features in many cases.